News
04-10-2015, 04:21 AM
Using induced pluripotent stem cells (iPSCs), a team led by Mount Sinai researchers has gained new insight into genetic changes that may turn a well known anti-cancer signaling gene into a driver of risk for bone cancers, where the survival rate has not improved in 40 years despite treatment advances.
More... (http://www.news-medical.net/news/20150410/Stem-cell-disease-model-reveals-how-tumor-suppressor-may-drive-bone-cancer.aspx)
More... (http://www.news-medical.net/news/20150410/Stem-cell-disease-model-reveals-how-tumor-suppressor-may-drive-bone-cancer.aspx)